Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 27, 2017
Pharmacy Choice - News - Front Page Healthcare News - March 27, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

3/27/17 - "Hypotensive Lipid-Containing Biodegradable Intraocular Implants and Related Implants" in Patent Application Approval Process (USPTO 20170065612)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventor Hughes, Patrick M., filed on November 21, 2016, was made available online on March 16, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or instit
3/27/17 - "N-Ethyl-N-Phenyl-1,2-Dihydro-4,5-Di-Hydroxy-1-Methyl-2-Oxo-3-Quinolinecarb- Oxamide, Preparation and Uses Thereof" in Patent Application Approval...
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Ioffe, Vladimir; Ulanenko, Konstantin; Laxer, Avital; Safadi, Muhammad; Licht, Danit; Lovinger, Ioana; Fristedt, Ulf Tomas, filed on November 17, 2016, was made available online on March 16, 2017, according to news reporting originating from Washing
3/27/17 - "Pharmaceutical Composition" in Patent Application Approval Process (USPTO 20170065542)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors ST. LAURENT, Joseph P.; JONES, Gerald S.; BRESSE, David M., filed on September 9, 2016, was made available online on March 16, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has
3/27/17 - "Progress-Supressing Or Improving Agent for Chronic Kidney Disease" in Patent Application Approval Process (USPTO 20170065563)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor IENAGA, Kazuharu, filed on February 25, 2015, was made available online on March 16, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Nippon Zoki Pharmaceutical Co.,
3/27/17 - 1 in 5 breast cancer patients could benefit from existing treatment, genetic study reveals
By a News Reporter-Staff News Editor at Clinical Trials Week Researchers from the Wellcome Trust Sanger Institute and their collaborators have discovered that a greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes. The results published in Nature Medicine open up the possibility of up to 20 per
3/27/17 - Accountable Care Organizations reduced medical costs without increasing drug costs
By a News Reporter-Staff News Editor at Managed Care Weekly Digest PITTSBURGH, A key component of the Affordable Care Act successfully saved Medicare $345 per person in medical costs in its first year without driving up prescription drug coverage costs, according to an analysis led by the University of Pittsburgh Graduate School of Public Health.
3/27/17 - Active Implants LLC Secures First Tranche of a $40 Million Equity Financing
By a News Reporter-Staff News Editor at Clinical Trials Week Active Implants, LLC, a company that develops orthopedic implant solutions, announced that it completed the first $10 million tranche of a $40 million Class D Units financing. The financing is to be comprised of $30 million from first-time investor LS Health Science Partners, L.P., with
3/27/17 - Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne
DUBLIN and BOSTON, March 27, 2017/ PRNewswire/ Allergan plc,, a leading global pharmaceutical company and Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, announced that two Phase 3 trials of sarecycline for the treatment of moder
3/27/17 - Allergan, Paratek Report Positive Results From Two Phase 3 Trials Of Sarecycline
WASHINGTON- Allergan plc and Paratek Pharmaceuticals Inc. announced that two Phase 3 trials of sarecycline for the treatment of moderate to severe acne met their 12 week primary efficacy endpoints. Based on these data, Allergan plans to file a New Drug Application to the U.S. Food& Drug Administration in the second half of this year. said David Nic
3/27/17 - Altasciences Clinical Research Companies Recognized for Leadership
By a News Reporter-Staff News Editor at Clinical Trials Week Altasciences Clinical Research proudly announces that its companies, Algorithme Pharma and Vince& Associates Clinical Research, have each been awarded multiple 2017 CRO Leadership Awards. This is the fourth consecutive year that Algorithme Pharma has been recognized by the industry.
3/27/17 - Amid the Affordable Care Act ("ACA") Reform, Medicaid managed care organizations continue to consolidate. Trusted Health Plan, Inc., acquires Harbor Health Plan, Inc. from Tenet Healthcare Corporation
Trusted Health Plan Inc., a Washington D.C. headquartered Managed Care Organization announces the acquisition of Harbor Health Plan, Inc. Plans include building brick and mortar Wellness Centers in Wayne, Oakland, and Macomb counties to improve member health outcomes, and establishing value-based contracts with providers. The Wellness Centers wil
3/27/17 - APEIRON Biologics Receives Green Light for Marketing Approval of a Neuroblastoma Immunotherapy in the European Union
APEIRON Biologics AG today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the approval of dinutuximab beta for immunotherapy of high risk neuroblastoma. The development was extended to multiple clinical trials across Europe and abroad, performed by the SIOPEN
3/27/17 - ArQule Announces Top-Line Results of Phase 3 Clinical Study of Tivantinib in Hepatocellular Carcinoma in Japan
ArQule, Inc. today reported that its partner, Kyowa Hakko Kirin, announced top-line results of the JET-HCC Phase 3 trial of tivantinib in Japan, and that the trial did not meet its primary endpoint of progression free survival. I would like to thank our partner, Kyowa Hakko Kirin, and all the participants in their study, said Paolo Pucci, Chi
3/27/17 - Asana BioSciences Announces FDA Acceptance of the IND Application for its Novel SYK-JAK Inhibitor for Evaluation in Atopic Dermatitis
By a News Reporter-Staff News Editor at Clinical Trials Week Asana BioSciences, LLC, a clinical stage biopharmaceutical company, announced that the FDA has accepted the IND application for ASN002, a novel dual SYK-JAK inhibitor, for atopic dermatitis. "We are extremely pleased with the efficient execution of our strategy to work on clinically va
3/27/17 - Asia Pacific Wearable Medical Devices Market: Industry Analysis, Future Growth, Business Prospects and Forecast to 2021
PUNE, MAHARASHTRA, INDIA, March 27, 2017/ EINPresswire.com/ Asia Pacific Wearable Medical Device Market including classification, application and industry chain overview; Then we deeply analyzed Asia Pacific growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, d
3/27/17 - AstraZeneca plc (ADR) (NYSE:AZN) Tagrisso Wins Approval In China
Tragrisso, a drug developed by AstraZeneca plc (ADR) (NYSE:AZN), has been granted approval in China. The treatment is designed to assist patients who are suffering from cancer and who have particular genetic mutations that are commonly found in the world's most populous country. China's approval of Tagrisso not only boosts the prospects of Astr
3/27/17 - Aurinia Highlights 48-Week Data from Open-Label AURION Study at 12th International Congress on SLE (LUPUS 2017) & the 7th Asian Congress on Autoimmunity (ACA 2017)
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, today announced the 48- week results from the Aurinia Early Urinary Protein Reduction Predicts Response Study open-label study of voclosporin for the treatment of lupus nephritis at the 12 th International Congress on Systemic Lup
3/27/17 - Boston Biomedical Associates to Present at the 2017 Outsourcing in Clinical Trials Israel Conference in March
By a News Reporter-Staff News Editor at Clinical Trials Week Boston Biomedical Associates will be one of the lead presenters and sponsors at the annual Outsourcing in Clinical Trials Israel conference in Tel Aviv March 21-22, 2017. Tami Abudi, the Co-CEO and Clinical Director of BBA Ltd. Israel, will present a program entitled "Outlining Global..
3/27/17 - Bracco Diagnostics Inc. announces the launch of the PROTOCO2L TOUCH Colon Insufflator for use in CT Colonography procedures
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, today announced the launch of its PROTOCO 2 L TOUCH Colon Insufflator. In the U.S., colon cancer is a leading cause of cancer related deaths. "The USPSTF Grade A classification places CTC on par with optical colonos
3/27/17 - Celltex autologous stem cell case study published in Stem Cells and Development demonstrates favorable response in pediatric patients
By a News Reporter-Staff News Editor at Clinical Trials Week Houston- based biotechnology company HYPERLINK " http://www.celltexbank.com/"\ nCelltex Therapeutics Corporation announces that Stem Cells and Development has published "HYPERLINK" http://online.liebertpub.com/doi/abs/10. 1089/ scd.2016.0196 "\ nAutologous Adipose Stem Cell Therapy for.
3/27/17 - Corindus Announces Partnership with WakeMed Health & Hospitals
By a News Reporter-Staff News Editor at Robotics& Machine Learning Corindus Vascular Robotics, Inc. announced that WakeMed Health& Hospitals will partner with Corindus to develop a national center of excellence to advance patient care and clinical robotics research and to train interventional cardiologists on robotic-assisted percutaneous coronar
3/27/17 - Cosmo Pharma Press release: EU filing for Qolotag
Cosmo announces further expansion of endoscopy pipeline with filing for EU approval of New Medical Device Qolotag to enhance diagnosis in sigmoidoscopies. Dublin- March 27, 2017- Cosmo Pharmaceuticals N.V. today announced that it has filed for EU approval of its new medical device named Qolotag. Approval is expected within June 2017 and marketing w
3/27/17 - Credence Research: Global Telehealth Market Size, Share, Growth, Outlook, Strategies and Forecast to 2022 - Credence Research
According to the latest report published by Credence Research, Inc. "Telehealth Market- Growth, Future Prospects and Competitive Analysis, 2016- 2022," the telehealth market was valued at USD 2,193.1 Mn in 2015, and is expected to reach USD 10,467.0 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022.. Phenomenal rise in the aging and chroni
3/27/17 - Credence Research: Global Teleradiology Market Size, Share, Growth, Outlook, Strategies and Forecast to 2023 - Credence Research
The latest market report published by Credence Research, Inc. "Global Teleradiology Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016- 2023," the Global Teleradiology market was valued at USD 3,200.6 Mn in 2015, and is expected to reach USD 10,841.0 Mn by 2023, expanding at a CAGR of 16.5% from 2016 to 2023.. Browse the
3/27/17 - CytoSorbents Announces CytoSorb Partnership with Dr. Reddy's Laboratories
By a News Reporter-Staff News Editor at Clinical Trials Week HYPERLINK " http://www.cytosorbents.com/"\ n CytoSorbents Corporation, manufacturer of the HYPERLINK " http://www.cytosorb.com/"\ nCytoSorb extracorporeal blood purification therapy that reduces excessive levels of inflammatory mediators in critically-ill and cardiac surgery patients
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415